US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ARCELLX, INC.

64.11

-2.4200-3.64%

Post-market: 63.00-1.1100-1.73%19:56 EST

Volume:890.34K

Turnover:57.21M

Market Cap:3.71B

PE:-16.29

High:66.96

Open:66.73

Low:63.15

Close:66.53

52wk High:94.07

52wk Low:47.86

Shares:57.82M

Float Shares:39.70M

Volume Ratio:1.21

T/O Rate:2.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.9351

EPS(LYR):-2.0040

ROE:-47.18%

ROA:-21.34%

PB:8.41

PE(LYR):-31.99

Loading ...

Overview Company News Filings

Rothschild & Co Redburn Downgrades Arcellx to Neutral From Buy, Adjusts PT to $82 From $113

MT Newswires Live

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Align Tech (ALGN) and M3 (OtherMTHRF)

Arcellx Price Target Maintained With a $115.00/Share by HC Wainwright & Co.

Arcellx stellt neue Daten zur Sicherheit und Wirksamkeit von Anito-cel auf Fachkongress vor

Arcellx Unveils Data Showing Anito-cel’s D-Domain Binder Achieves High Target Specificity in Multiple Myeloma

Analysts Offer Insights on Healthcare Companies: Steris (STE), Arcellx Inc (ACLX) and BioCryst (BCRX)

Arcellx Showcases CAR T Advances and Access Solutions for Multiple Myeloma at Tandem Meetings

Arcellx Unveils New Data Highlighting Anito-cel's Efficacy and Market Impact in Multiple Myeloma

Canaccord Genuity Keeps Their Buy Rating on Arcellx Inc (ACLX)

Arcellx Director David Charles Lubner Reports Disposal of Common Shares

Citi Reaffirms Their Buy Rating on Arcellx Inc (ACLX)

Arcellx Coverage Assumed by UBS at Buy

A Look At Arcellx (ACLX) Valuation After New US$209.2 Million Shelf Registration Filing

Simply Wall St.

Reassessing Arcellx (ACLX) Valuation After Wells Fargo’s Positive CAR‑T Coverage Launch

Simply Wall St.

Innovative Drug Sector Boost! Wells Fargo Bets on Arcellx (ACLX.US) to Reshape Myeloma Treatment Landscape, Predicts Over 50% Stock Surge

Is Wells Fargo’s Anito-cel Endorsement Reframing the Investment Case for Arcellx (ACLX)?

Simply Wall St.

What Arcellx (ACLX)'s Anito‑cel Phase 2 Data Means For Shareholders

Simply Wall St.

Cancer Study Buoys These Small Biotechs -- Barrons.com

Arcellx (ACLX) Valuation Check After Strong Phase 2 iMMagine-1 Results for Anito-cel in Multiple Myeloma

Simply Wall St.

BUZZ-U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACLX\",,,,,undefined,":{"symbol":"ACLX","market":"US","secType":"STK","nameCN":"ARCELLX, INC.","latestPrice":64.11,"timestamp":1771621200000,"preClose":66.53,"halted":0,"volume":890335,"hourTrading":{"tag":"盘后","latestPrice":63,"preClose":64.11,"latestTime":"19:56 EST","volume":7942,"amount":508020.092,"timestamp":1771635419758,"change":-1.11,"changeRate":-0.017314,"amplitude":0.035704},"delay":0,"changeRate":-0.03637456786412147,"floatShares":39702900,"shares":57822871,"eps":-3.935093,"marketStatus":"Market Closed","change":-2.42,"latestTime":"02-20 16:00:00 EST","open":66.73,"high":66.96,"low":63.145,"amount":57210484.02076,"amplitude":0.057343,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.935093,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"listingDate":1643950800000,"exchange":"NASDAQ","adjPreClose":66.53,"preHourTrading":{"tag":"盘前","latestPrice":65.5,"preClose":66.53,"latestTime":"09:25 EST","volume":782,"amount":52058.482899999995,"timestamp":1771597523499,"change":-1.03,"changeRate":-0.015482,"amplitude":0.024049},"postHourTrading":{"tag":"盘后","latestPrice":63,"preClose":64.11,"latestTime":"19:56 EST","volume":7942,"amount":508020.092,"timestamp":1771635419758,"change":-1.11,"changeRate":-0.017314,"amplitude":0.035704},"volumeRatio":1.206288,"impliedVol":0.6844,"impliedVolPercentile":0.8446},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACLX\",,,,,undefined,":{"symbol":"ACLX","floatShares":39702900,"roa":"-21.34%","roe":"-47.18%","lyrEps":-2.004026,"volumeRatio":1.206288,"shares":57822871,"dividePrice":0,"high":66.96,"amplitude":0.057343,"preClose":66.53,"low":63.145,"week52Low":47.8601,"pbRate":"8.41","psRate":"103.27","week52High":94.07,"institutionHeld":0,"latestPrice":64.11,"eps":-3.935093,"divideRate":0,"volume":890335,"delay":0,"ttmEps":-3.935093,"open":66.73,"prevYearClose":65.2,"prevWeekClose":68.5,"prevMonthClose":68.31,"prevQuarterClose":65.2,"fiveDayClose":68.65,"twentyDayClose":68.62,"sixtyDayClose":90.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-05","symbol":"ACLX","fiscalQuarterEnding":"2025/09","expectedEps":-0.96,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"post","actualEps":-0.99},{"market":"US","date":"2025-08-07","symbol":"ACLX","fiscalQuarterEnding":"2025/06","expectedEps":-1.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.94},{"market":"US","date":"2025-05-08","symbol":"ACLX","fiscalQuarterEnding":"2025/03","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.35,"buy":0.5,"hold":0.15,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":20,"updateTime":1770958800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACLX","date":"2026-02-19","current":-16.291864,"percent":0.544041,"low":-142.50735,"twenty":-52.012399,"median":-19.479962,"eighty":-8.581549,"high":-3.230096,"avg":-29.645636,"sd":29.003615,"marketCap":3992091013},"quantilePoints":[{"date":"2022-02-04","current":-17.558229,"twenty":-16.805733,"median":-15.67699,"eighty":-15.67699,"marketCap":563531371},{"date":"2022-02-11","current":-18.422732,"twenty":-18.556193,"median":-18.021766,"eighty":-16.429486,"marketCap":591277578},{"date":"2022-02-18","current":-19.311358,"twenty":-18.693766,"median":-18.422732,"eighty":-17.643945,"marketCap":619798025},{"date":"2022-02-25","current":-18.35771,"twenty":-19.302688,"median":-18.455243,"eighty":-17.783355,"marketCap":589190715},{"date":"2022-03-04","current":-19.506422,"twenty":-19.484748,"median":-18.56903,"eighty":-17.880887,"marketCap":626058612},{"date":"2022-03-11","current":-18.075951,"twenty":-19.380714,"median":-18.49859,"eighty":-17.837539,"marketCap":580147647},{"date":"2022-03-18","current":-16.873055,"twenty":-19.302688,"median":-18.476917,"eighty":-17.783355,"marketCap":541540699},{"date":"2022-03-25","current":-8.943909,"twenty":-19.181315,"median":-18.422732,"eighty":-17.01009,"marketCap":581076855},{"date":"2022-04-01","current":-7.909804,"twenty":-18.81286,"median":-18.18432,"eighty":-15.723306,"marketCap":513892077},{"date":"2022-04-08","current":-7.112223,"twenty":-18.709965,"median":-17.880887,"eighty":-8.487363,"marketCap":462074031},{"date":"2022-04-14","current":-7.112223,"twenty":-18.645167,"median":-17.772518,"eighty":-7.711784,"marketCap":462074031},{"date":"2022-04-22","current":-5.891099,"twenty":-18.63947,"median":-17.638281,"eighty":-7.167229,"marketCap":382738814},{"date":"2022-04-29","current":-6.012111,"twenty":-18.617796,"median":-16.710501,"eighty":-7.112223,"marketCap":390600863},{"date":"2022-05-06","current":-5.060515,"twenty":-18.574448,"median":-15.79278,"eighty":-6.930705,"marketCap":328776572},{"date":"2022-05-13","current":-3.991699,"twenty":-18.552775,"median":-8.943909,"eighty":-6.122123,"marketCap":318254187},{"date":"2022-05-20","current":-3.494417,"twenty":-18.49859,"median":-8.173831,"eighty":-5.891099,"marketCap":278606359},{"date":"2022-05-27","current":-5.174425,"twenty":-18.455243,"median":-7.711784,"eighty":-5.132022,"marketCap":412551724},{"date":"2022-06-03","current":-5.864348,"twenty":-18.446573,"median":-7.216734,"eighty":-5.165944,"marketCap":467558620},{"date":"2022-06-10","current":-10.944693,"twenty":-18.427067,"median":-7.46141,"eighty":-5.298919,"marketCap":872609404},{"date":"2022-06-17","current":-8.674595,"twenty":-18.370714,"median":-7.711784,"eighty":-5.406253,"marketCap":691616789},{"date":"2022-06-24","current":-9.843017,"twenty":-18.305693,"median":-7.909804,"eighty":-5.454874,"marketCap":784773938},{"date":"2022-07-01","current":-10.210827,"twenty":-18.166981,"median":-8.242784,"eighty":-5.506672,"marketCap":814099010},{"date":"2022-07-08","current":-11.083688,"twenty":-18.088955,"median":-8.568331,"eighty":-5.624944,"marketCap":883691345},{"date":"2022-07-15","current":-9.151316,"twenty":-17.997925,"median":-8.685383,"eighty":-5.8079,"marketCap":729625295},{"date":"2022-07-22","current":-10.759796,"twenty":-17.859213,"median":-9.047612,"eighty":-5.875048,"marketCap":857867774},{"date":"2022-07-29","current":-11.380131,"twenty":-17.805028,"median":-9.403565,"eighty":-5.928503,"marketCap":907326477},{"date":"2022-08-05","current":-10.87508,"twenty":-17.768183,"median":-9.64184,"eighty":-5.99561,"marketCap":867059214},{"date":"2022-08-12","current":-10.183378,"twenty":-17.744342,"median":-9.843017,"eighty":-6.027513,"marketCap":811910572},{"date":"2022-08-19","current":-8.241841,"twenty":-17.654291,"median":-9.64184,"eighty":-6.079218,"marketCap":779463868},{"date":"2022-08-26","current":-7.755392,"twenty":-17.284159,"median":-9.403565,"eighty":-6.254136,"marketCap":733458412},{"date":"2022-09-02","current":-8.417889,"twenty":-16.808033,"median":-9.189744,"eighty":-6.520363,"marketCap":796113462},{"date":"2022-09-09","current":-8.969199,"twenty":-16.695329,"median":-9.115851,"eighty":-6.624873,"marketCap":848252979},{"date":"2022-09-16","current":-8.635633,"twenty":-16.489429,"median":-9.151316,"eighty":-6.693081,"marketCap":816706380},{"date":"2022-09-23","current":-8.088957,"twenty":-15.862255,"median":-9.068805,"eighty":-6.931805,"marketCap":765005011},{"date":"2022-09-30","current":-8.69586,"twenty":-15.67699,"median":-8.969199,"eighty":-6.954907,"marketCap":822402294},{"date":"2022-10-07","current":-7.959237,"twenty":-14.961448,"median":-8.899664,"eighty":-7.038563,"marketCap":752736889},{"date":"2022-10-14","current":-8.941401,"twenty":-12.093791,"median":-8.904255,"eighty":-7.081608,"marketCap":845624096},{"date":"2022-10-21","current":-9.145247,"twenty":-12.010348,"median":-8.906613,"eighty":-7.112223,"marketCap":864902572},{"date":"2022-10-28","current":-10.196904,"twenty":-11.715003,"median":-8.943909,"eighty":-7.113323,"marketCap":964361987},{"date":"2022-11-04","current":-10.298827,"twenty":-11.506394,"median":-8.985413,"eighty":-7.121024,"marketCap":974001225},{"date":"2022-11-11","current":-10.368319,"twenty":-11.456987,"median":-9.066488,"eighty":-7.137525,"marketCap":980573433},{"date":"2022-11-18","current":-5.477972,"twenty":-11.424049,"median":-8.985413,"eighty":-7.081608,"marketCap":933210843},{"date":"2022-11-25","current":-5.570644,"twenty":-11.380131,"median":-8.956554,"eighty":-6.930705,"marketCap":948998244},{"date":"2022-12-02","current":-5.210251,"twenty":-11.259358,"median":-8.908971,"eighty":-6.122123,"marketCap":887602794},{"date":"2022-12-09","current":-7.213006,"twenty":-11.144074,"median":-8.848744,"eighty":-5.984609,"marketCap":1228786081},{"date":"2022-12-16","current":-8.198938,"twenty":-11.083688,"median":-8.79315,"eighty":-6.012111,"marketCap":1396746492},{"date":"2022-12-23","current":-8.093394,"twenty":-11.05075,"median":-8.783884,"eighty":-6.050615,"marketCap":1378766395},{"date":"2022-12-30","current":-7.97498,"twenty":-10.980482,"median":-8.756087,"eighty":-6.107821,"marketCap":1358593605},{"date":"2023-01-06","current":-8.641706,"twenty":-10.951982,"median":-8.742349,"eighty":-6.320143,"marketCap":1472175188},{"date":"2023-01-13","current":-8.278739,"twenty":-10.935863,"median":-8.69586,"eighty":-6.554466,"marketCap":1410341198},{"date":"2023-01-20","current":-8.294185,"twenty":-10.911012,"median":-8.674595,"eighty":-6.627074,"marketCap":1412972432},{"date":"2023-01-27","current":-8.736953,"twenty":-10.880713,"median":-8.638669,"eighty":-6.752487,"marketCap":1488401128},{"date":"2023-02-03","current":-8.417748,"twenty":-10.876792,"median":-8.600519,"eighty":-6.932905,"marketCap":1434022301},{"date":"2023-02-10","current":-7.812803,"twenty":-10.828966,"median":-8.586513,"eighty":-6.973609,"marketCap":1330965652},{"date":"2023-02-17","current":-7.491023,"twenty":-10.748817,"median":-8.566141,"eighty":-7.047411,"marketCap":1276148286},{"date":"2023-02-24","current":-7.156373,"twenty":-10.73125,"median":-8.533711,"eighty":-7.051336,"marketCap":1219138225},{"date":"2023-03-03","current":-7.264491,"twenty":-10.72279,"median":-8.516148,"eighty":-7.081171,"marketCap":1237556860},{"date":"2023-03-10","current":-6.92984,"twenty":-10.69741,"median":-8.494975,"eighty":-7.081171,"marketCap":1180546799},{"date":"2023-03-17","current":-7.67122,"twenty":-10.634879,"median":-8.427874,"eighty":-7.110037,"marketCap":1306846011},{"date":"2023-03-24","current":-7.550231,"twenty":-10.529123,"median":-8.402303,"eighty":-7.110037,"marketCap":1286234681},{"date":"2023-03-31","current":-7.812011,"twenty":-10.516053,"median":-8.370125,"eighty":-7.110474,"marketCap":1473962354},{"date":"2023-04-06","current":-6.97021,"twenty":-10.500682,"median":-8.339054,"eighty":-7.110037,"marketCap":1315132266},{"date":"2023-04-14","current":-7.429144,"twenty":-10.492997,"median":-8.329865,"eighty":-7.110037,"marketCap":1401723368},{"date":"2023-04-18","current":-8.69438,"twenty":-10.485311,"median":-8.339054,"eighty":-7.110037,"marketCap":1640446904},{"date":"2023-05-12","current":-11.258515,"twenty":-10.706517,"median":-8.399358,"eighty":-7.112223,"marketCap":2138915191},{"date":"2023-05-19","current":-10.408002,"twenty":-10.706517,"median":-8.417818,"eighty":-7.112223,"marketCap":1977333024},{"date":"2023-05-26","current":-10.817249,"twenty":-10.759276,"median":-8.445823,"eighty":-7.114593,"marketCap":2055082526},{"date":"2023-06-02","current":-11.196181,"twenty":-10.844532,"median":-8.494975,"eighty":-7.116201,"marketCap":2127072806},{"date":"2023-06-09","current":-10.279165,"twenty":-10.805758,"median":-8.501281,"eighty":-7.12082,"marketCap":1952856328},{"date":"2023-06-16","current":-9.357097,"twenty":-10.759666,"median":-8.533711,"eighty":-7.133205,"marketCap":1777679980},{"date":"2023-06-23","current":-8.515868,"twenty":-10.759146,"median":-8.532363,"eighty":-7.133205,"marketCap":1617861559},{"date":"2023-06-30","current":-7.874209,"twenty":-10.737708,"median":-8.508574,"eighty":-7.134021,"marketCap":1495958018},{"date":"2023-07-07","current":-8.149567,"twenty":-10.729054,"median":-8.496262,"eighty":-7.144126,"marketCap":1548270955},{"date":"2023-07-14","current":-8.619442,"twenty":-10.714653,"median":-8.494975,"eighty":-7.154115,"marketCap":1637538902},{"date":"2023-07-21","current":-8.523446,"twenty":-10.687608,"median":-8.499415,"eighty":-7.162887,"marketCap":1619301364},{"date":"2023-07-28","current":-8.359242,"twenty":-10.66659,"median":-8.508289,"eighty":-7.170529,"marketCap":1588105576},{"date":"2023-08-04","current":-8.553761,"twenty":-10.628937,"median":-8.519657,"eighty":-7.179009,"marketCap":1625060587},{"date":"2023-08-11","current":-8.584075,"twenty":-10.561311,"median":-8.533711,"eighty":-7.196448,"marketCap":1630819809},{"date":"2023-08-18","current":-9.219336,"twenty":-10.526431,"median":-8.54121,"eighty":-7.208372,"marketCap":1687728436},{"date":"2023-08-25","current":-9.22726,"twenty":-10.514466,"median":-8.553761,"eighty":-7.211976,"marketCap":1689179206},{"date":"2023-09-01","current":-9.46765,"twenty":-10.4945,"median":-8.560077,"eighty":-7.213006,"marketCap":1733185879},{"date":"2023-09-08","current":-9.43595,"twenty":-10.480919,"median":-8.566141,"eighty":-7.214497,"marketCap":1727382801},{"date":"2023-09-15","current":-8.801956,"twenty":-10.459724,"median":-8.583721,"eighty":-7.219362,"marketCap":1611321246},{"date":"2023-09-22","current":-9.245752,"twenty":-10.435959,"median":-8.589764,"eighty":-7.238749,"marketCap":1692564335},{"date":"2023-09-29","current":-9.62879,"twenty":-10.42715,"median":-8.601759,"eighty":-7.262947,"marketCap":1762684857},{"date":"2023-10-06","current":-9.272168,"twenty":-10.418107,"median":-8.622851,"eighty":-7.264491,"marketCap":1697400233},{"date":"2023-10-13","current":-8.783464,"twenty":-10.408002,"median":-8.6346,"eighty":-7.28251,"marketCap":1607936118},{"date":"2023-10-20","current":-8.545716,"twenty":-10.402966,"median":-8.637643,"eighty":-7.315744,"marketCap":1564413035},{"date":"2023-10-27","current":-8.434767,"twenty":-10.389107,"median":-8.637643,"eighty":-7.324074,"marketCap":1544102263},{"date":"2023-11-03","current":-10.76998,"twenty":-10.389107,"median":-8.641706,"eighty":-7.338629,"marketCap":1971595655},{"date":"2023-11-10","current":-11.744747,"twenty":-10.435959,"median":-8.679989,"eighty":-7.376688,"marketCap":2150040295},{"date":"2023-11-17","current":-19.609641,"twenty":-10.517557,"median":-8.69438,"eighty":-7.453896,"marketCap":2539958375},{"date":"2023-11-24","current":-20.026868,"twenty":-10.6503,"median":-8.709759,"eighty":-7.493597,"marketCap":2594000043},{"date":"2023-12-01","current":-19.744958,"twenty":-10.73125,"median":-8.731935,"eighty":-7.511103,"marketCap":2557485403},{"date":"2023-12-08","current":-21.759673,"twenty":-10.807795,"median":-8.751765,"eighty":-7.541993,"marketCap":2818443365},{"date":"2023-12-15","current":-19.282626,"twenty":-10.881639,"median":-8.756087,"eighty":-7.55332,"marketCap":2497601393},{"date":"2023-12-22","current":-19.500636,"twenty":-10.959271,"median":-8.783464,"eighty":-7.571339,"marketCap":2525839381},{"date":"2023-12-29","current":-21.380034,"twenty":-10.986875,"median":-8.790834,"eighty":-7.58833,"marketCap":2769270316},{"date":"2024-01-05","current":-21.789652,"twenty":-11.051802,"median":-8.79315,"eighty":-7.599227,"marketCap":2822326421},{"date":"2024-01-12","current":-21.757579,"twenty":-11.179003,"median":-8.799869,"eighty":-7.61317,"marketCap":2818172122},{"date":"2024-01-19","current":-21.320583,"twenty":-11.309204,"median":-8.803506,"eighty":-7.622824,"marketCap":2761569808},{"date":"2024-01-26","current":-23.79021,"twenty":-11.506394,"median":-8.833656,"eighty":-7.629003,"marketCap":3081450778},{"date":"2024-02-02","current":-25.586303,"twenty":-11.834585,"median":-8.900655,"eighty":-7.650626,"marketCap":3314091484},{"date":"2024-02-09","current":-24.680238,"twenty":-12.093791,"median":-8.941401,"eighty":-7.679333,"marketCap":3196732557},{"date":"2024-02-16","current":-25.574276,"twenty":-15.67699,"median":-8.960864,"eighty":-7.711784,"marketCap":3312533622},{"date":"2024-02-23","current":-24.25527,"twenty":-16.710501,"median":-8.972426,"eighty":-7.711784,"marketCap":3141688104},{"date":"2024-03-01","current":-48.351237,"twenty":-17.718333,"median":-8.996996,"eighty":-7.722705,"marketCap":3417948942},{"date":"2024-03-08","current":-52.856368,"twenty":-17.843007,"median":-9.031208,"eighty":-7.722705,"marketCap":3736416655},{"date":"2024-03-15","current":-51.960118,"twenty":-18.097625,"median":-9.066488,"eighty":-7.73815,"marketCap":3673060714},{"date":"2024-03-22","current":-53.8049,"twenty":-18.444406,"median":-9.080387,"eighty":-7.741015,"marketCap":3803468360},{"date":"2024-03-28","current":-52.617368,"twenty":-18.55711,"median":-9.099141,"eighty":-7.74902,"marketCap":3719521738},{"date":"2024-04-05","current":-46.31374,"twenty":-18.655384,"median":-9.126878,"eighty":-7.754518,"marketCap":3273918282},{"date":"2024-04-12","current":-44.939489,"twenty":-18.865515,"median":-9.150984,"eighty":-7.760133,"marketCap":3176772505},{"date":"2024-04-19","current":-41.085333,"twenty":-19.208953,"median":-9.155936,"eighty":-7.767696,"marketCap":2904322167},{"date":"2024-04-26","current":-38.733292,"twenty":-19.328697,"median":-9.223298,"eighty":-7.783506,"marketCap":2738056384},{"date":"2024-05-03","current":-40.173163,"twenty":-19.521804,"median":-9.235185,"eighty":-7.807021,"marketCap":2839840886},{"date":"2024-05-10","current":-55.595092,"twenty":-19.751724,"median":-9.258751,"eighty":-7.812645,"marketCap":2809998309},{"date":"2024-05-17","current":-55.880041,"twenty":-20.063659,"median":-9.27481,"eighty":-7.818981,"marketCap":2824400775},{"date":"2024-05-24","current":-53.593606,"twenty":-20.657279,"median":-9.293301,"eighty":-7.825384,"marketCap":2708835220},{"date":"2024-05-31","current":-55.297847,"twenty":-20.747805,"median":-9.309595,"eighty":-7.829132,"marketCap":2794974361},{"date":"2024-06-07","current":-54.345166,"twenty":-20.985361,"median":-9.349092,"eighty":-7.846268,"marketCap":2746822046},{"date":"2024-06-14","current":-59.055644,"twenty":-21.5801,"median":-9.383117,"eighty":-7.863623,"marketCap":2984908491},{"date":"2024-06-21","current":-57.785403,"twenty":-21.783656,"median":-9.398967,"eighty":-7.875829,"marketCap":2920705405},{"date":"2024-06-28","current":-57.287892,"twenty":-21.810254,"median":-9.401609,"eighty":-7.879068,"marketCap":2895559196},{"date":"2024-07-05","current":-57.923012,"twenty":-22.059066,"median":-9.428025,"eighty":-7.882587,"marketCap":2927660739},{"date":"2024-07-12","current":-62.74993,"twenty":-22.399842,"median":-9.450087,"eighty":-7.893725,"marketCap":3171632468},{"date":"2024-07-15","current":-66.084314,"twenty":-22.494458,"median":-9.451015,"eighty":-7.899085,"marketCap":3340165569},{"date":"2024-08-02","current":-62.083053,"twenty":-22.512098,"median":-9.459333,"eighty":-7.904444,"marketCap":3137925847},{"date":"2024-08-09","current":-52.200053,"twenty":-24.026749,"median":-9.478217,"eighty":-7.94935,"marketCap":2813165235},{"date":"2024-08-16","current":-64.695935,"twenty":-24.625714,"median":-9.494384,"eighty":-7.959928,"marketCap":3486593339},{"date":"2024-08-23","current":-66.291888,"twenty":-25.243121,"median":-9.513636,"eighty":-7.960101,"marketCap":3572602426},{"date":"2024-08-30","current":-67.309308,"twenty":-25.590312,"median":-9.55883,"eighty":-7.962122,"marketCap":3627433218},{"date":"2024-09-06","current":-70.191998,"twenty":-25.822842,"median":-9.601127,"eighty":-7.970039,"marketCap":3782787131},{"date":"2024-09-13","current":-74.580868,"twenty":-26.509206,"median":-9.62879,"eighty":-7.976653,"marketCap":4019312118},{"date":"2024-09-20","current":-85.213903,"twenty":-38.611167,"median":-9.7435,"eighty":-7.979184,"marketCap":4592347656},{"date":"2024-09-27","current":-83.927166,"twenty":-39.254962,"median":-9.843017,"eighty":-7.984762,"marketCap":4523002831},{"date":"2024-10-04","current":-76.00725,"twenty":-39.711801,"median":-9.936343,"eighty":-7.987851,"marketCap":4096182739},{"date":"2024-10-11","current":-82.690303,"twenty":-40.63754,"median":-10.029667,"eighty":-7.994029,"marketCap":4456345789},{"date":"2024-10-18","current":-95.029012,"twenty":-43.27454,"median":-10.101067,"eighty":-8.008115,"marketCap":5121303538},{"date":"2024-10-25","current":-86.261247,"twenty":-45.272596,"median":-10.145943,"eighty":-8.017149,"marketCap":4648791119},{"date":"2024-10-31","current":-86.590412,"twenty":-46.909747,"median":-10.196904,"eighty":-8.029039,"marketCap":4666530493},{"date":"2024-11-08","current":-131.865847,"twenty":-49.306214,"median":-10.26421,"eighty":-8.045774,"marketCap":5330413129},{"date":"2024-11-15","current":-127.190452,"twenty":-51.258055,"median":-10.298827,"eighty":-8.059806,"marketCap":5141419623},{"date":"2024-11-22","current":-116.67597,"twenty":-51.954143,"median":-10.365424,"eighty":-8.082352,"marketCap":4716392717},{"date":"2024-11-29","current":-117.813032,"twenty":-52.342705,"median":-10.405484,"eighty":-8.089844,"marketCap":4762356186},{"date":"2024-12-06","current":-115.605793,"twenty":-52.676915,"median":-10.433179,"eighty":-8.095029,"marketCap":4673132981},{"date":"2024-12-13","current":-111.592632,"twenty":-53.29373,"median":-10.479821,"eighty":-8.101993,"marketCap":4510908971},{"date":"2024-12-20","current":-100.609948,"twenty":-53.794397,"median":-10.523739,"eighty":-8.104206,"marketCap":4066955930},{"date":"2024-12-27","current":-105.706663,"twenty":-54.080532,"median":-10.607573,"eighty":-8.106266,"marketCap":4272980423},{"date":"2025-01-03","current":-105.345478,"twenty":-54.498,"median":-10.675002,"eighty":-8.132823,"marketCap":4258380262},{"date":"2025-01-10","current":-96.663673,"twenty":-54.751643,"median":-10.726858,"eighty":-8.145525,"marketCap":3907435654},{"date":"2025-01-17","current":-89.640641,"twenty":-55.145418,"median":-10.759471,"eighty":-8.16624,"marketCap":3623543636},{"date":"2025-01-24","current":-87.473534,"twenty":-55.875807,"median":-10.793615,"eighty":-8.18084,"marketCap":3535942671},{"date":"2025-01-31","current":-90.403142,"twenty":-56.771327,"median":-10.87508,"eighty":-8.186139,"marketCap":3654366198},{"date":"2025-02-07","current":-91.286037,"twenty":-57.294243,"median":-10.901297,"eighty":-8.191323,"marketCap":3690055480},{"date":"2025-02-14","current":-85.226164,"twenty":-57.573696,"median":-10.944693,"eighty":-8.201274,"marketCap":3445097225},{"date":"2025-02-21","current":-87.767833,"twenty":-57.923012,"median":-10.966295,"eighty":-8.205669,"marketCap":3547839098},{"date":"2025-02-28","current":-30.924135,"twenty":-58.393002,"median":-11.041363,"eighty":-8.212976,"marketCap":3319643991},{"date":"2025-03-07","current":-35.111592,"twenty":-58.282914,"median":-11.083688,"eighty":-8.228319,"marketCap":3769159223},{"date":"2025-03-14","current":-36.636848,"twenty":-58.210934,"median":-11.174708,"eighty":-8.231374,"marketCap":3932892378},{"date":"2025-03-21","current":-36.5396,"twenty":-57.923012,"median":-11.259358,"eighty":-8.23841,"marketCap":3922453016},{"date":"2025-03-28","current":-35.065528,"twenty":-57.89549,"median":-11.40758,"eighty":-8.247676,"marketCap":3764214262},{"date":"2025-04-04","current":-31.958715,"twenty":-57.747296,"median":-11.517373,"eighty":-8.271017,"marketCap":3430704109},{"date":"2025-04-11","current":-29.000333,"twenty":-57.584282,"median":-11.777033,"eighty":-8.272561,"marketCap":3113127719},{"date":"2025-04-17","current":-31.063011,"twenty":-57.54194,"median":-11.906231,"eighty":-8.278739,"marketCap":3334552088},{"date":"2025-04-25","current":-32.741816,"twenty":-57.436086,"median":-12.071832,"eighty":-8.294185,"marketCap":3514768447},{"date":"2025-05-02","current":-33.618824,"twenty":-57.298477,"median":-12.362891,"eighty":-8.307056,"marketCap":3608913572},{"date":"2025-05-09","current":-19.076405,"twenty":-57.298477,"median":-15.67699,"eighty":-8.325232,"marketCap":3098389708},{"date":"2025-05-16","current":-19.83122,"twenty":-57.287892,"median":-16.672572,"eighty":-8.329865,"marketCap":3220986790},{"date":"2025-05-23","current":-22.124788,"twenty":-56.959746,"median":-16.987583,"eighty":-8.348244,"marketCap":3593508102},{"date":"2025-05-30","current":-21.605682,"twenty":-56.908936,"median":-17.718333,"eighty":-8.355022,"marketCap":3509194847},{"date":"2025-06-06","current":-22.477645,"twenty":-56.803083,"median":-17.79961,"eighty":-8.358737,"marketCap":3650819073},{"date":"2025-06-13","current":-22.565859,"twenty":-56.762858,"median":-17.880887,"eighty":-8.377431,"marketCap":3665146816},{"date":"2025-06-20","current":-21.653182,"twenty":-56.745922,"median":-18.075951,"eighty":-8.385122,"marketCap":3516909785},{"date":"2025-06-27","current":-21.975503,"twenty":-56.527864,"median":-18.314363,"eighty":-8.390091,"marketCap":3569261153},{"date":"2025-07-03","current":-22.786394,"twenty":-56.184899,"median":-18.433569,"eighty":-8.393047,"marketCap":3700966173},{"date":"2025-07-11","current":-23.363179,"twenty":-55.875807,"median":-18.49859,"eighty":-8.396509,"marketCap":3794647568},{"date":"2025-07-18","current":-24.072285,"twenty":-55.75971,"median":-18.596122,"eighty":-8.400536,"marketCap":3909820577},{"date":"2025-07-25","current":-23.841571,"twenty":-55.476194,"median":-18.645167,"eighty":-8.404278,"marketCap":3872348019},{"date":"2025-08-01","current":-24.221571,"twenty":-55.196227,"median":-18.758194,"eighty":-8.411443,"marketCap":3934067527},{"date":"2025-08-08","current":-24.140142,"twenty":-55.001457,"median":-18.98944,"eighty":-8.417804,"marketCap":3920841918},{"date":"2025-08-15","current":-21.199525,"twenty":-54.917915,"median":-19.064872,"eighty":-8.419693,"marketCap":3985277416},{"date":"2025-08-22","current":-21.172973,"twenty":-54.835919,"median":-19.214967,"eighty":-8.424419,"marketCap":3980286114},{"date":"2025-08-29","current":-20.724556,"twenty":-54.75376,"median":-19.296992,"eighty":-8.430377,"marketCap":3895988568},{"date":"2025-09-05","current":-21.288028,"twenty":-54.745292,"median":-19.428671,"eighty":-8.435385,"marketCap":4001915089},{"date":"2025-09-12","current":-22.916491,"twenty":-54.699813,"median":-19.506422,"eighty":-8.441044,"marketCap":4308048284},{"date":"2025-09-19","current":-23.595018,"twenty":-54.538331,"median":-19.596486,"eighty":-8.457109,"marketCap":4435603781},{"date":"2025-09-26","current":-23.130375,"twenty":-54.456678,"median":-19.744958,"eighty":-8.475312,"marketCap":4348255995},{"date":"2025-10-03","current":-24.261744,"twenty":-54.336698,"median":-19.805003,"eighty":-8.49549,"marketCap":4560940922},{"date":"2025-10-10","current":-26.076064,"twenty":-54.258366,"median":-19.943184,"eighty":-8.498295,"marketCap":4902013231},{"date":"2025-10-17","current":-26.211769,"twenty":-54.071712,"median":-20.02574,"eighty":-8.501672,"marketCap":4927524331},{"date":"2025-10-24","current":-24.801615,"twenty":-54.007144,"median":-20.18747,"eighty":-8.504247,"marketCap":4662430731},{"date":"2025-10-31","current":-25.813504,"twenty":-53.872977,"median":-20.22597,"eighty":-8.509805,"marketCap":4852654800},{"date":"2025-11-07","current":-22.447952,"twenty":-53.794397,"median":-20.470846,"eighty":-8.517384,"marketCap":4891476038},{"date":"2025-11-14","current":-23.197824,"twenty":-53.72063,"median":-20.561907,"eighty":-8.52496,"marketCap":5054875382},{"date":"2025-11-21","current":-23.768349,"twenty":-53.591489,"median":-20.621302,"eighty":-8.531553,"marketCap":5179194555},{"date":"2025-11-28","current":-19.294369,"twenty":-53.583021,"median":-20.621302,"eighty":-8.533711,"marketCap":4204300950},{"date":"2025-12-05","current":-18.163933,"twenty":-53.40307,"median":-20.543545,"eighty":-8.533711,"marketCap":3957975519},{"date":"2025-12-12","current":-19.289062,"twenty":-52.856368,"median":-20.385293,"eighty":-8.545716,"marketCap":4203144492},{"date":"2025-12-19","current":-17.017575,"twenty":-52.744337,"median":-20.208078,"eighty":-8.548708,"marketCap":3708180717},{"date":"2025-12-26","current":-17.5138,"twenty":-52.702511,"median":-20.107169,"eighty":-8.552094,"marketCap":3816309486},{"date":"2026-01-02","current":-17.301511,"twenty":-52.686782,"median":-20.02574,"eighty":-8.553433,"marketCap":3770051189},{"date":"2026-01-09","current":-17.06534,"twenty":-52.664212,"median":-19.943184,"eighty":-8.553761,"marketCap":3718588834},{"date":"2026-01-16","current":-18.129436,"twenty":-52.631025,"median":-19.841398,"eighty":-8.555277,"marketCap":3950458546},{"date":"2026-01-23","current":-18.209044,"twenty":-52.551643,"median":-19.771075,"eighty":-8.559319,"marketCap":3967805408},{"date":"2026-01-30","current":-18.113515,"twenty":-52.42318,"median":-19.681058,"eighty":-8.564776,"marketCap":3946989174},{"date":"2026-02-06","current":-17.763239,"twenty":-52.307042,"median":-19.596486,"eighty":-8.566141,"marketCap":3870662984},{"date":"2026-02-13","current":-18.217005,"twenty":-52.124991,"median":-19.506422,"eighty":-8.572304,"marketCap":3969540094},{"date":"2026-02-19","current":-18.320496,"twenty":-52.012399,"median":-19.479962,"eighty":-8.581549,"marketCap":3992091013}],"updateTime":1771636924848},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610929284","title":"Rothschild & Co Redburn Downgrades Arcellx to Neutral From Buy, Adjusts PT to $82 From $113","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929284","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929284?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:11","pubTimestamp":1770901908,"startTime":"0","endTime":"0","summary":"Rothschild & Co Redburn Downgrades Arcellx to Neutral From Buy, Adjusts PT to $82 From $113","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2609837645","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Arcellx Inc (ACLX), Align Tech (ALGN) and M3 (OtherMTHRF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609837645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609837645?lang=en_us&edition=fundamental","pubTime":"2026-02-05 18:50","pubTimestamp":1770288606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Arcellx Inc (ACLX – Research Report), Align Tech (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcellx-inc-aclx-align-tech-algn-and-m3-othermthrf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-arcellx-inc-aclx-align-tech-algn-and-m3-othermthrf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1974910355.USD","BK4504","XBI","BK4581","XLV","BK4137","BK4588","BK4534","HCSG","LU2023250843.SGD","ALGN","BK4585","LU1917777945.USD","ACLX","LU2106854487.HKD","BK4198","LU0128526141.USD","BK4139","LU0029874061.USD","LU2023250504.SGD","LABU"],"gpt_icon":0},{"id":"2609941153","title":"Arcellx Price Target Maintained With a $115.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2609941153","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609941153?lang=en_us&edition=fundamental","pubTime":"2026-02-05 02:04","pubTimestamp":1770228240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 04, 2026 13:04 ET (18:04 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACLX"],"gpt_icon":0},{"id":"2608672773","title":"Arcellx stellt neue Daten zur Sicherheit und Wirksamkeit von Anito-cel auf Fachkongress vor","url":"https://stock-news.laohu8.com/highlight/detail?id=2608672773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608672773?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:00","pubTimestamp":1770213656,"startTime":"0","endTime":"0","summary":"Arcellx Inc. hat bekanntgegeben, dass eine spte Abstract-Prsentation zu ihrem neuartigen D-Domain Binder in Anitocabtagene Autoleucel  auf den Tandem Meetings vom 4. bis 7. Februar 2026 in Salt Lake City vorgestellt wird. Die prsentierten prklinischen Daten untersuchen die Zielgerichtetheit und Sicherheit des D-Domain Binders im Vergleich zu anderen BCMA-gerichteten CAR-T-Zelltherapien bei der Behandlung von Multiplem Myelom. Ergebnisse zeigen, dass der D-Domain Binder weder tonische Signale noch Off-Target-Aktivitt aufweist. Die Prsentation der Studienergebnisse steht dem Fachpublikum auf der Tagung sowie online auf der Website von Arcellx zur Verfügung.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcellx Inc. published the origina","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL96kVrr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2608101367","title":"Arcellx Unveils Data Showing Anito-cel’s D-Domain Binder Achieves High Target Specificity in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2608101367","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608101367?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:00","pubTimestamp":1770213656,"startTime":"0","endTime":"0","summary":"Arcellx Inc. has announced that a late-breaking abstract detailing the unique high target-specificity of its novel D-Domain binder in anitocabtagene autoleucel  has been accepted for presentation at the 2026 Tandem Meetings, scheduled for February 4-7, 2026. The presentation will discuss preclinical study results showing that the D-Domain binder in anito-cel confers potent anti-tumor activity while minimizing tonic signaling and off-target reactivity. According to the abstract, anito-cel demonstrated no cases of delayed neurotoxicities or immune effector cell-associated enterocolitis to date, and the study found no tonic signaling or off-target activity with the D-Domain binder. Results will be presented during the late-breaking poster session on February 5, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL24fZlB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2607010273","title":"Analysts Offer Insights on Healthcare Companies: Steris (STE), Arcellx Inc (ACLX) and BioCryst (BCRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2607010273","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607010273?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:21","pubTimestamp":1769775685,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Steris (STE – Research Report), Arcellx Inc (ACLX – ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-steris-ste-arcellx-inc-aclx-and-biocryst-bcrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-steris-ste-arcellx-inc-aclx-and-biocryst-bcrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","STE","BK4082","BCRX","XLV","LU1892829315.USD","BK4588","BK4137","BK4139","BK4585","BK4547","LABU","HCSG","XBI","BK4581","ACLX","LU0128526141.USD"],"gpt_icon":0},{"id":"2605382534","title":"Arcellx Showcases CAR T Advances and Access Solutions for Multiple Myeloma at Tandem Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2605382534","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605382534?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:01","pubTimestamp":1769029319,"startTime":"0","endTime":"0","summary":"Arcellx Inc. will participate in the 2026 Tandem Meetings, taking place from February 4-7, 2026, at the Salt Palace Convention Center in Salt Lake City, Utah. The company will present three studies highlighting its D-Domain platform technology and commercial progress for anito-cel in multiple myeloma, including research on its pharmacology, treatment sequencing outcomes, and geographic inequities in CAR T-cell therapy access.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcellx Inc. published the original content used to generate this news brief on January 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL5cGkw0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACLX"],"gpt_icon":0},{"id":"2605543841","title":"Arcellx Unveils New Data Highlighting Anito-cel's Efficacy and Market Impact in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2605543841","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605543841?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:00","pubTimestamp":1769029228,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcellx Inc. published the original content used to generate this news brief via Business Wire  on January 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL7Qmsl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2605015741","title":"Canaccord Genuity Keeps Their Buy Rating on Arcellx Inc (ACLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605015741","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605015741?lang=en_us&edition=fundamental","pubTime":"2026-01-21 19:56","pubTimestamp":1768996573,"startTime":"0","endTime":"0","summary":"In a report released yesterday, John Newman from Canaccord Genuity maintained a Buy rating on Arcellx Inc, with a price target of $130.00. The comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-arcellx-inc-aclx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-arcellx-inc-aclx-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACLX"],"gpt_icon":0},{"id":"2605123429","title":"Arcellx Director David Charles Lubner Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605123429","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605123429?lang=en_us&edition=fundamental","pubTime":"2026-01-21 09:00","pubTimestamp":1768957218,"startTime":"0","endTime":"0","summary":"David Charles Lubner, Director at Arcellx Inc., reported a disposal of common shares of Arcellx Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcellx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL6BzM3C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcellx Director David Charles Lubner Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2603683998","title":"Citi Reaffirms Their Buy Rating on Arcellx Inc (ACLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603683998?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:18","pubTimestamp":1768303108,"startTime":"0","endTime":"0","summary":"In a report released on January 9, Geoff Meacham from Citi maintained a Buy rating on Arcellx Inc, with a price target of $110.00. The company’s sh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-reaffirms-their-buy-rating-on-arcellx-inc-aclx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-reaffirms-their-buy-rating-on-arcellx-inc-aclx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACLX"],"gpt_icon":0},{"id":"2601738623","title":"Arcellx Coverage Assumed by UBS at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2601738623","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601738623?lang=en_us&edition=fundamental","pubTime":"2026-01-08 04:52","pubTimestamp":1767819120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ACLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2026 15:52 ET (20:52 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACLX"],"gpt_icon":0},{"id":"2601707860","title":"A Look At Arcellx (ACLX) Valuation After New US$209.2 Million Shelf Registration Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2601707860","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601707860?lang=en_us&edition=fundamental","pubTime":"2026-01-06 14:17","pubTimestamp":1767680246,"startTime":"0","endTime":"0","summary":"Arcellx (ACLX) has filed a shelf registration to offer up to $209.2 million in common stock, covering 3,208,367 shares tied to an employee stock ownership plan, which is raising fresh questions about future capital needs.\nSee our latest analysis for Arcellx.\nThe shelf registration comes after a roughly 30% decline in the 90 day share price return and an 11% drop over 30 days, even though the 3 year total shareholder return is close to a 2x gain. Some investors may see the capital raising...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/a-look-at-arcellx-aclx-valuation-after-new-us2092-million-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/a-look-at-arcellx-aclx-valuation-after-new-us2092-million-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ACLX","DCF"],"gpt_icon":0},{"id":"2594253318","title":"Reassessing Arcellx (ACLX) Valuation After Wells Fargo’s Positive CAR‑T Coverage Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2594253318","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594253318?lang=en_us&edition=fundamental","pubTime":"2025-12-25 23:22","pubTimestamp":1766676140,"startTime":"0","endTime":"0","summary":"Wells Fargo just launched coverage on Arcellx (ACLX), spotlighting its experimental CAR T therapy for multiple myeloma as a potential future treatment pillar, and investors are now reassessing what the stock might be worth.\nSee our latest analysis for Arcellx.\nThe upbeat coverage comes after a choppy stretch, with Arcellx posting a steep double digit year to date share price loss but still delivering a strong three year total shareholder return. This suggests momentum is pausing rather than...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/reassessing-arcellx-aclx-valuation-after-wells-fargos-positi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/reassessing-arcellx-aclx-valuation-after-wells-fargos-positi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0154236417.USD","LU1074936037.SGD","LU0314106906.USD","LU1280957306.USD","LU0417517546.SGD","LU0868494708.USD","LU0072461881.USD","LU0640476718.USD","LU0029864427.USD","LU0310799852.SGD","LU0310800379.SGD","LU0289960550.SGD","LU1363072403.SGD","BK4588","LU1506573853.SGD","LU0128525929.USD","LU1201861249.SGD","LU1267930227.SGD","LU0211328371.USD","DCF","ACLX","BK4022","LU0128525689.USD","IE00B7SZLL34.SGD","LU0211327993.USD","LU0648001328.SGD","LU1791807156.HKD","LU0267386448.USD","CAR","LU0130102774.USD","LU0310800965.SGD","LU2461242641.AUD","LU0980610538.SGD","LU0708994859.HKD","LU0251142724.SGD","LU0175139822.USD","LU2361044865.SGD","LU1267930490.SGD","BK4585","LU0149725797.USD","LU1668664300.SGD","LU0256863811.USD","LU0052756011.USD","LU1267930573.SGD","LU1035773651.USD","LU0477156953.USD","BK4504","LU2361045086.USD","LU0942090050.USD","IE0002270589.USD"],"gpt_icon":0},{"id":"1109917561","title":"Innovative Drug Sector Boost! Wells Fargo Bets on Arcellx (ACLX.US) to Reshape Myeloma Treatment Landscape, Predicts Over 50% Stock Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1109917561","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109917561?lang=en_us&edition=fundamental","pubTime":"2025-12-23 15:16","pubTimestamp":1766474192,"startTime":"0","endTime":"0","summary":"Wall Street financial giant Wells Fargo has initiated coverage on emerging biotech player Arcellx (ACLX.US) with an \"Overweight\" rating, highlighting its experimental CAR-T therapy \"anito-cel\" as a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","LU0162691827.USD","LU0128525929.USD","BK4504","LU0787776722.HKD","LU0868494708.USD","LU1035773651.USD","LU0251131958.USD","LU0149725797.USD","LU0106831901.USD","LU0154236417.USD","LU0211328371.USD","LU0310800965.SGD","ACLX","LU0289960550.SGD","LU1791807156.HKD","IE00B19Z3B42.SGD","LU1280957306.USD","BK4588","LU1506573853.SGD","IE00B19Z3581.USD","BK4139","LU0648001328.SGD","LU1267930573.SGD","LU0208291251.USD","LU1074936037.SGD","LU1267930227.SGD","LU0477156953.USD","LU0267386448.USD","LU2361044865.SGD","LU1668664300.SGD","LU0980610538.SGD","LU0070302665.USD","IE0002270589.USD","LU0640476718.USD","BK1161","BK4501","LU0310799852.SGD","LU0310800379.SGD","LU0072461881.USD","LU0708994859.HKD","LU1267930490.SGD","LU2361045086.USD","LU2461242641.AUD","LU0256863811.USD","LU0868494617.USD","LU0314106906.USD","LU0175139822.USD","06978","BK1574","LU0130517989.USD","LU0211327993.USD","LU0942090050.USD","LU1201861249.SGD","LU0742534661.SGD","LU1363072403.SGD","BK4559","LU2236285917.USD","IE000M9KFDE8.USD","LU0971096721.USD","LU1069347547.HKD","LU0052756011.USD","LU0417517546.SGD","LU0128525689.USD","LU0320765489.SGD","159992","BK4207","LU0048573561.USD","LU1814569148.SGD","LU0130102774.USD","LU0683600562.USD","LU2361044949.HKD","BK4585","LU0251142724.SGD","IE00B7SZLL34.SGD","WFC"],"gpt_icon":0},{"id":"2593849372","title":"Is Wells Fargo’s Anito-cel Endorsement Reframing the Investment Case for Arcellx (ACLX)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2593849372","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593849372?lang=en_us&edition=fundamental","pubTime":"2025-12-23 13:12","pubTimestamp":1766466765,"startTime":"0","endTime":"0","summary":"Earlier this year, Wells Fargo initiated coverage of Arcellx with an overweight rating, highlighting the company’s experimental CAR-T therapy anito-cel for multiple myeloma as a potential future pillar in blood cancer treatment.\nThe endorsement spotlights how Arcellx’s oncology immunotherapy platform is drawing increased attention as a possible contributor to next-generation multiple myeloma care options.\nWe’ll now examine how Wells Fargo’s focus on anito-cel as a potential multiple myeloma...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/is-wells-fargos-anito-cel-endorsement-reframing-the-investme","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/is-wells-fargos-anito-cel-endorsement-reframing-the-investme","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0052756011.USD","LU1069347547.HKD","BK4207","BK4585","IE00B19Z3581.USD","LU0310800379.SGD","LU0128525929.USD","BK4501","LU0149725797.USD","LU0154236417.USD","LU0477156953.USD","LU1506573853.SGD","LU0211328371.USD","ACLX","LU0070302665.USD","LU1201861249.SGD","LU0029864427.USD","LU0868494617.USD","LU0708994859.HKD","LU1668664300.SGD","LU0106831901.USD","LU0130517989.USD","LU0942090050.USD","LU1363072403.SGD","LU0787776722.HKD","LU1035773651.USD","LU1267930573.SGD","LU0211327993.USD","LU0417517546.SGD","LU0971096721.USD","LU0048573561.USD","LU0175139822.USD","LU0256863811.USD","LU2361044949.HKD","LU1791807156.HKD","LU0072461881.USD","LU0251142724.SGD","LU0128525689.USD","IE00B7SZLL34.SGD","LU1074936037.SGD","LU1267930490.SGD","LU2236285917.USD","BK4588","LU0320765489.SGD","BK4139","BK4559","LU2361044865.SGD","LU0683600562.USD","IE0002270589.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2590512696","title":"What Arcellx (ACLX)'s Anito‑cel Phase 2 Data Means For Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2590512696","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590512696?lang=en_us&edition=fundamental","pubTime":"2025-12-11 22:33","pubTimestamp":1765463598,"startTime":"0","endTime":"0","summary":"Arcellx, Inc. recently reported new positive data from its pivotal Phase 2 iMMagine-1 trial of anitocabtagene autoleucel (anito-cel) in heavily pretreated relapsed or refractory multiple myeloma, highlighting deep and durable responses with a manageable safety profile and no delayed or non-ICANS neurotoxicities observed to date.\nWith anito-cel partnered alongside Kite, a Gilead company, and holding Fast Track, Orphan Drug, and RMAT designations, Arcellx is positioning the therapy as a...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/what-arcellx-aclxs-anitocel-phase-2-data-means-for-sharehold","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/what-arcellx-aclxs-anitocel-phase-2-data-means-for-sharehold","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2590739329","title":"Cancer Study Buoys These Small Biotechs -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2590739329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590739329?lang=en_us&edition=fundamental","pubTime":"2025-12-10 04:31","pubTimestamp":1765312260,"startTime":"0","endTime":"0","summary":"The effectiveness of a leukemia drug from Terns Pharmaceuticals exceeded the hopes of many doctors and investors when the biotech firm reported early phase trial results this week.Terns shares jumped as much as 50% on the news that cancer cell counts fell over 99% in nearly three-fourths of the 38 leukemia patients treated for six months with the firm's once-daily pill. That's nearly twice the effectiveness of Scemblix, a similar drug from Novartis that has reached annual sales of a billion dollars.Arcellx was another stock lifted by study results reported at the American Society of Hematology meeting in Orlando, Fla. The shares popped 13% as a pivotal trial of its multiple-myeloma cell therapy showed fewer side effects with comparable efficacy to an established therapy from Legend Biotech. Shares of Legend slipped more than 10%.In about a hundred patients whose cancers advanced despite three or more other treatments, the Arcellx CAR-T eliminated measurable cancers in about three-quart","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","IE00BSNM7G36.USD","LU0985320562.USD","CAR","LU2505996509.AUD","BK4581","IE00BFXG1179.USD","ACLX","LU2750360641.GBP","NVS","LU2430703251.USD","LU2129689605.HKD","LU2471134523.USD","BK4578","IE00BVYPNW00.USD","IE0002270589.USD","LEGN","LU0203345920.USD","BK4585","LU2089984988.USD","LU2468319806.SGD","BK4568","IE00B1BXHZ80.USD","LU1935042991.SGD","IE00BBT3K403.USD","LU2471134796.USD","SG9999002224.SGD","IE00B3T34201.USD","LU1074936037.SGD","LU1032466523.USD","IE00B19Z3581.USD","IE00B2B36J28.USD","LU0640476718.USD","IE00BZ1G4Q59.USD","BK4532","JNJ","IE00BJJMRZ35.SGD","LU0889566641.SGD","LU1929549753.HKD","IE00BJT1NW94.SGD","LU1066051225.USD","BK4505","BK4588","LU1261432733.SGD","LU0345770993.USD","LU1066051498.USD","LU1496350502.SGD","IE00B19Z3B42.SGD","LU1914381329.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2590298315","title":"Arcellx (ACLX) Valuation Check After Strong Phase 2 iMMagine-1 Results for Anito-cel in Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2590298315","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590298315?lang=en_us&edition=fundamental","pubTime":"2025-12-09 12:31","pubTimestamp":1765254718,"startTime":"0","endTime":"0","summary":"Arcellx (ACLX) just put fresh clinical data on the table, and it is the kind investors tend to pay attention to. The company reported pivotal Phase 2 results for its multiple myeloma CAR T, anito cel.\nSee our latest analysis for Arcellx.\nThe upbeat iMMagine 1 readout has arrived after a choppy stretch, with the stock’s 30 day share price return still negative even as the 90 day move turns positive and three year total shareholder returns remain very strong. This hints that momentum may be...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/arcellx-aclx-valuation-check-after-strong-phase-2-immagine-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aclx/arcellx/news/arcellx-aclx-valuation-check-after-strong-phase-2-immagine-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ACLX","DCF","BK4139"],"gpt_icon":0},{"id":"2590368328","title":"BUZZ-U.S. STOCKS ON THE MOVE-Five Below, Boeing, Instacart","url":"https://stock-news.laohu8.com/highlight/detail?id=2590368328","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590368328?lang=en_us&edition=fundamental","pubTime":"2025-12-09 02:45","pubTimestamp":1765219558,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Five Below, Boeing, InstacartEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: http","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nL6N3XE0MP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FULC","NEE","RIOT","FCX","FIVE","APA","COMP","LNG","ROK","EXE","ACLX","SCCO","GPCR","NRIX","GM","APD","XOM","USCB","AGIO","KYMR","ALB","WBD","WYNN","CRH","COP","AR","LEN","TPL","EOG","CVX","BKR","DYN","MMM","OCUL","OMF","INCY","FANG","CFLT","HUT","JEF"],"gpt_icon":1}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}